Skip to main content

RUFINAMIDE

Tracking # 20-811177

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

RUFINAMIDE IS ONE OF THE ANTI-SEIZURE DRUGS (ASD) USED AS AN ADD-ON THERAPY TO TREAT SEIZURES ASSOCIATED WITH LENNOX GASTAUT SYNDROME, AND IT IS STRUCTURALLY UNRELATED TO OTHER TRADITIONAL ASDS. THIS CME ACTIVITY PROVIDES A BRIEF AND ILLUSTRATIVE REVIEW OF THIS DRUG'S FDA-APPROVED INDICATIONS AND PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES. THIS ACTIVITY WILL ALSO HIGHLIGHT THE SIDE EFFECTS, CONTRAINDICATIONS, AND DOSING REGIMENS OF THIS DRUG AND WILL ALSO SHED LIGHT ON THE PRACTICE PARAMETERS OF THE AMERICAN ACADEMY OF NEUROLOGY GUIDELINES REGARDING THE UTILITY OF THIS DRUG IN CLINICAL PRACTICE.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I